Your Messages Inbox (0) 
Your Unread Messages
See AllMost Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
International Braz J Urol, 11/06/09
Stephenson AJ et al. – The pathologic features and outcome of patients treated at low PSA levels are favorable and similar for patients with PSA < or = 2.5 versus 2.6–4.0. However, > 50% of the former have potentially biologically unimportant cancer. We failed to identify a therapeutic benefit to the diagnosis of cancers below accepted PSA thresholds for biopsy.
Related Articles
Should Prostate Specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging
The Journal of Urology, 11/12/09
Relevance Score: 69%
Natural History of Persistently Elevated Prostate Specific Antigen After Radical Prostatectomy: Results From the SEARCH Database
The Journal of Urology, 10/16/09
Relevance Score: 69%
Men Older Than 70 Years Have Higher Risk Prostate Cancer and Poorer Survival in the Early and Late Prostate Specific Antigen Eras
The Journal of Urology, 10/21/09
Relevance Score: 68%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 67%
Proton MRS detects metabolic changes in hormone sensitive and resistant human prostate cancer models CWR22 and CWR22r
Magnetic Resonance in Medicine, 10/09/09
Relevance Score: 66%
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Annals of Oncology, 11/24/09
Clinical Implications and Prognostic Values of Topoisomerase-II Alpha Expression in Primary Non-Muscle-Invasive Bladder Cancer
Urology, 11/24/09
Association of age and response to androgen-deprivation therapy with or without radiotherapy for prostate cancer: data from CaPSURE
BJU International, 11/24/09
Today in Prostate...keeping you current
Receive free subspecialty "5-minute updates" via email
Multicentre phase I/II study of PI-88, a heparanase inhibitor in combination with docetaxel in patients with metastatic castrate-resistant prostate cancer
Annals of Oncology, 11/24/09
Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy
BJU International, 11/24/09
An Alternative Minimally Invasive Technique for Large Prostates (>80 mL): Transvesical Prostatectomy Through a 3-cm Incision
Urology, 11/24/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Color Doppler Sonography Reliably Identifies Testicular Torsion in Boys
Urology, 11/24/09
Long-term Outcome of Patients With a Negative Work-up for Asymptomatic Microhematuria
Urology, 11/24/09
Transfer of cysto-urethroscopy skills from a virtual-reality simulator to the operating room: a randomized controlled trial
BJU International, 11/23/09
Article Search
Sponsor